Clostridium difficile-associated diarrhea

被引:10
作者
Bujanda, Luis [1 ]
Cosme, Angel [2 ]
机构
[1] Hosp Donostia, Serv Aparato Digest, Ctr Invest Biomed Enfermedades Hepat & Digest, CIBEREHD, San Sebastian, Spain
[2] Univ Basque Country, Inst Salud Carlos III, San Sebastian, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2009年 / 32卷 / 01期
关键词
Clostridium difficile; Diagnosis; Treatment; Diarrhea; Antibiotics; INTRAVENOUS IMMUNOGLOBULIN; CASE SERIES; COLITIS; VANCOMYCIN; DISEASE; OUTCOMES; METRONIDAZOLE; PREVENTION; DIAGNOSIS; TOLEVAMER;
D O I
10.1016/j.gastrohep.2008.02.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Clostridium difficile is the most frequent cause of nosocomial diarrhea and is a significant cause of morbidity among hospitalized patients. The inflammation is produced as a result of a non-specific response to toxins. In the last few years, a hypervirulent strain, NAP1/BI/027, has been reported. Symptoms usually consist of abdominal pain and diarrhea. The diagnosis should be suspected in any patient who develops diarrhea during antibiotic therapy or 6-8 weeks after treatment. Diagnosis should be confirmed by the detection of CD toxin in stool and by colonoscopy in special situations. The treatment of choice is metronidazole or vancomycin. In some patients who do not respond to this therapy or who have complications, subtotal colectomy may be required. Relapse is frequent and must be distinguished from reinfection. Prevention and control in healthcare settings requires careful attention. © 2008 Elsevier España, S.L. All rights reserved.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 50 条
  • [31] Management of Severe Clostridium difficile-Associated Diarrhea
    Krier, Michael J.
    Triadafilopoulos, George
    DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (06) : 1199 - 1202
  • [32] Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding
    Bliss, DZ
    Johnson, S
    Savik, K
    Clabots, CR
    Willard, K
    Gerding, DN
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (12) : 1012 - +
  • [33] The Prognostic Value of Inflammatory Markers in Clostridium difficile-associated Diarrhea
    Nseir, William
    Khamisy-farah, Rola
    Amara, Amir
    Farah, Raymond
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2019, 21 (10): : 658 - 661
  • [34] Clostridium difficile-associated diarrhea:: an emerging threat to pregnant women
    Rouphael, Nadine G.
    O'Donnell, Judith A.
    Bhatnagar, Julu
    Lewis, Felicia
    Polgreen, Philip M.
    Beekmann, Susan
    Guarner, Jeannette
    Killgore, George E.
    Coffman, Becky
    Campbell, Jennifer
    Zaki, Sherif R.
    McDonald, L. Clifford
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (06) : 635.e1 - 635.e6
  • [35] Clostridium difficile-associated disease: Adherence with current guidelines at a tertiary medical center
    Curtin, Bryan F.
    Zarbalian, Yousef
    Flasar, Mark H.
    von Rosenvinge, Erik
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (46) : 8647 - 8651
  • [36] Clostridium difficile-associated diarrhea:: Predictors of severity in patients presenting to the emergency department
    Andrews, CN
    Raboud, J
    Kassen, BO
    Enns, R
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2003, 17 (06): : 369 - 373
  • [37] Fecal transplant against relapsing Clostridium difficile-associated diarrhea in 32 patients
    Jorup-Ronstrom, Christina
    Hakanson, Anders
    Sandell, Staffan
    Edvinsson, Ove
    Midtvedt, Tore
    Persson, Anna-Karin
    Norin, Elisabeth
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (05) : 548 - 552
  • [38] Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment?
    Matthias G Hautmann
    Matthias Hipp
    Oliver Kölbl
    Radiation Oncology, 6
  • [39] Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy
    Mizui, T.
    Teramachi, H.
    Tachi, T.
    Tamura, K.
    Shiga, H.
    Komada, N.
    Umeda, M.
    Koda, A.
    Aoyama, S.
    Goto, C.
    Tsuchiya, T.
    PHARMAZIE, 2013, 68 (08): : 706 - 710
  • [40] Clostridium difficile-associated infections - How dangerous are the new strains?
    Kola, A.
    INTERNIST, 2010, 51 (02): : 154 - +